Biological E. Limited

Biological E. Limited ~~ An Original Page of Biological E. Ltd ~~

Follow us on:
https://www.linkedin.com/company/biological-e--ltd Biological E.

Limited (BE), the first private sector biological products company in India and the first pharmaceuticals company in South India was established in 1953. Originally incorporated as Biological Products Private Limited, and launched by Dr. Vijay Kumar Datla, today, BE is a globally recognized vaccine manufacturer and has supplied over 2 Billion Doses of Vaccines till date all over the world. BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO, many global markets, and in India to the National Immunization Program, various State Governments, PSUs, Indian Armed Forces and the domestic retail market. With a mission to improve health and survival of people and contribute to the societies BE serves by providing equitable access to quality vaccines and therapeutics. BE has a long and richly textured history of supporting public health programs in India for over five decades. Our portfolio of WHO pre-qualified vaccines include the 5-in-1 Pentavalent and a Japanese Encephalitis vaccine and our future offerings promise to be even more exciting.

Progress in science rarely happens in isolation. It grows when knowledge is shared, opportunities expand, and diverse pe...
08/03/2026

Progress in science rarely happens in isolation. It grows when knowledge is shared, opportunities expand, and diverse perspectives come together. Sometimes the formula for innovation is simple: Give to Gain.

Measure the colour.Multiply the laughter.Make the memories count.Here’s to a Holi that’s bold, bright, and beautifully u...
04/03/2026

Measure the colour.
Multiply the laughter.
Make the memories count.
Here’s to a Holi that’s bold, bright, and beautifully unforgettable.

NATIONAL SAFETY DAY 2026Engage. Educate. Empower.
04/03/2026

NATIONAL SAFETY DAY 2026
Engage. Educate. Empower.

A decisive step forward in stopping polio outbreaks — at speed and at scale.Biological E. Limited has won Phase II Pre-Q...
19/02/2026

A decisive step forward in stopping polio outbreaks — at speed and at scale.

Biological E. Limited has won Phase II Pre-Qualification from the World Health Organization for nOPV2, validating fully integrated manufacturing from drug substance to finished vaccine — all at one site.

700M+ doses already powering global response. Now with stronger, end-to-end WHO-qualified capacity when the world needs it most.

Link to the full article is in the comments.

15/02/2026

04/02/2026

15/01/2026

01/01/2026

16/12/2025

01/12/2025

Address

Biological E. Limited (Corporate Office), Road No-35, Jubilee Hills
Hyderabad
500012

Alerts

Be the first to know and let us send you an email when Biological E. Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Biological E. Limited:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

About us

Biological E. Limited (BE), founded in 1953, the first private sector biological products company in India and the first pharmaceutical company in South India. Originally incorporated as Biological Products Private Limited, BE is a globally recognized vaccine manufacturer and has supplied over two billion doses of vaccines till date all over the world.

BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO and several global markets, and in India to the National Immunization Programme, various State Governments, PSUs, Indian Armed Forces and the domestic retail market. With a mission to improve health & survival of people, BE serves by providing equitable access to quality vaccines and therapeutics. BE has a long and richly textured history of supporting public health programmes in India for over five decades. BE’s portfolio of WHO pre-qualified vaccines include the 5-in-1 Pentavalent and a Japanese Encephalitis vaccine and its future offerings promise to be even more exciting.